The upregulation of canonical interferon-gamma signaling has been correlated with GBM progression, and its expression within the tumor microenvironment plays a crucial role in overall survival, particularly in pediatric diffuse midline glioma (DMG) patients (70, 71). The gene discussed is IFNG; the disease is diffuse midline glioma.